Kamakshya Trivedi, co-head of FX, rates and EM strategy at Goldman Sachs, discusses the market outlook for Russia and other emerging markets after the latest round of economic sanctions.
CNBC’s Steve Sedgwick reports from the Polish border town of Medyka where Ukrainians have been arriving, fleeing their homes in the wake of the Russian invasion.
Aneeka Gupta, equity and commodity strategist at WisdomTree, discusses monetary policy in the U.S. and China and how the latter’s decision-making will impact emerging markets.
Henry Foy, European diplomatic correspondent at the Financial Times, talks to CNBC ahead of U.S.-Russia talks in Geneva. He says the Europeans and Americans don’t want to give ground on Putin’s demands, while what the Americans want, Putin has said is not on the table.
Professor David Heymann from the London School of Hygiene and Tropical Medicine discusses the outlook for the latest surge in Covid-19 cases in the U.K.
Former Ifo President Professor Hans-Werner Sinn discusses inflationary pressures in Germany and Europe and what he views as the ECB’s flawed monetary policy.
Russian President Vladimir Putin thinks cryptocurrencies have value — but he’s not convinced they can replace the U.S. dollar in settling oil trades. “I believe that it has value,” he told CNBC’s Hadley Gamble at the Russian Energy Week event in Moscow. “But I don’t believe it can be used in the oil trade.” Story: https://t.co/igXKM1cCFZ?amp=1 https://cnb.cx/2Z4mdWf https://bit.ly/3aOExEZ _____________________________ Subscribe to CNBC International TV: http://cnb.cx/2wAkfMv Subscribe to CNBC International: http://cnb.cx/2gft82z Like our Facebook page https://www.facebook.com/cnbcinternat… Follow us on Instagram https://www.instagram.com/cnbcinterna… Follow us on Twitter https://twitter.com/cnbci
CNBC’s Charlotte Reed reports on Sanofi’s announcement that its Covid-19 mRNA vaccine will not pursue phase 3 trials despite positive initial results. Instead the French pharma firm said it wants to focus on its protein-based Covid-19 vaccine it is developing in parallel with GSK, and use the mRNA technology for other diseases including influenza.
Top economic historian Niall Ferguson, Milbank Family Senior Fellow at the Hoover Institution at Stanford University, joins CNBC at the Ambrosetti forum to discuss the outlook for U.S. inflation and geopolitics.